rs28942100
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000187.4(HGD):c.688C>T(p.Pro230Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P230T) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000187.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HGD | NM_000187.4 | c.688C>T | p.Pro230Ser | missense_variant | 10/14 | ENST00000283871.10 | NP_000178.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HGD | ENST00000283871.10 | c.688C>T | p.Pro230Ser | missense_variant | 10/14 | 1 | NM_000187.4 | ENSP00000283871.5 | ||
HGD | ENST00000494453.1 | c.106C>T | p.Pro36Ser | missense_variant | 2/5 | 3 | ENSP00000419163.1 | |||
HGD | ENST00000475447.2 | c.200+193C>T | intron_variant | 3 | ENSP00000417977.2 | |||||
HGD | ENST00000492108.5 | n.180+2568C>T | intron_variant | 2 | ENSP00000419838.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152154Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 250950Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135612
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1461830Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 727228
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152270Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74448
ClinVar
Submissions by phenotype
Alkaptonuria Pathogenic:6Other:1
Pathogenic, no assertion criteria provided | research | Department Of Human Genetics, Institute Of Clinical And Translational Research, Biomedical Research Center, Slovak Academy Of Sciences | - | The variant was originally described in AKU patient in PMID:10594001. It has been submitted to the HGD gene mutation database (http://hgddatabase.cvtisr.sk/, DB-ID: AKU_00074). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 30, 1998 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 04, 2022 | - - |
not provided, no classification provided | literature only | GeneReviews | - | Frequent missense variant - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The HGD c.688C>T (p.Pro230Ser) variant has been identified in a homozygous state in 18 individuals (15 of whom were from one family) and in a compound heterozygous state in eight individuals (including two siblings) with alkaptonuria (Fernandez-Canon et al. 1996; Ramos et al. 1998; Vilboux et al. 2009; Zatkova et al. 2012; Usher et al. 2015). The p.Pro230Ser variant has also been detected in a heterozygous state in at least five unaffected family members and has been shown to segregate with disease in an autosomal recessive pattern in three pedigrees (Fernandez-Canon et al. 1996; Ramos et al. 1998). The p.Pro230Ser variant was absent from 118 controls and is reported at a frequency of 0.00005 in the European (non-Finnish) population of the Exome Aggregation Consortium. Functional studies in E. coli demonstrated that the variant resulted in a complete absence of enzyme activity (Fernandez-Canon et al. 1996). Based on the collective evidence, the p.Pro230Ser variant is classified as pathogenic for alkaptonuria. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 21, 2023 | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 230 of the HGD protein (p.Pro230Ser). This variant is present in population databases (rs28942100, gnomAD 0.009%). This missense change has been observed in individual(s) with alkaptonuria (PMID: 8782815, 9674916, 10482952, 10970188, 19862842, 25681086). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 3165). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HGD protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Mar 08, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at